Role of nox2-based NADPH 0xidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia

Norifumi Urao, Hyoe Inomata, Masooma Razvi, Ha Won Kim, Kishore Wary, Ronald McKinney, Tohru Fukai, Masuko Fukai

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs). Postnatal neovascularization depends on not only angiogenesis but also vasculogenesis, which is mediated through mobilization of EPCs from BM and their recruitment to the ischemic sites. Reactive oxygen species (ROS) derived from Nox2-based NADPH oxidase play an important role in postnatal neovascularization; however, their role in BM and EPC function is unknown. Here we show that hindlimb ischemia of mice significantly increases Nox2 expression and ROS production in BM-mononuclear cells (BMCs), which is associated with an increase in circulating EPC-like cells. Mice lacking Nox2 show reduction of ischemia-induced flow recovery, ROS levels in BMCs, as well as EPC mobilization from BM. Transplantation of wild-type (WT)-BM into Nox2-deficient mice rescues the defective neovascularization, whereas WT mice transplanted with Nox2-deficient BM show reduced flow recovery and capillary density compared to WT-BM transplanted control. Intravenous infusion of WT- and Nox2-deficient BMCs into WT mice reveals that neovascularization and homing capacity are impaired in Nox2-deficient BMCs in vivo. In vitro, Nox2-deficient c-kitLin BM stem/progenitor cells show impaired chemotaxis and invasion as well as polarization of actins in response to stromal derived factor (SDF), which is associated with blunted SDF-1-mediated phosphorylation of Akt. In conclusion, Nox2-derived ROS in BM play a critical role in mobilization, homing, and angiogenic capacity of EPCs and BM stem/progenitor cells, thereby promoting revascularization of ischemic tissue. Thus, NADPH oxidase in BM and EPCs is potential therapeutic targets for promoting neovascularization in ischemic cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)212-220
Number of pages9
JournalCirculation research
Volume103
Issue number2
DOIs
StatePublished - Jul 18 2008
Externally publishedYes

Fingerprint

Hindlimb
NADP
Bone Marrow Cells
Stem Cells
Ischemia
Bone Marrow
Reactive Oxygen Species
NADPH Oxidase
Chemotaxis
Endothelial Progenitor Cells
Bone Marrow Transplantation
Intravenous Infusions
Actins
Cardiovascular Diseases
Phosphorylation

Keywords

  • Angiogenesis
  • Endothelial progenitor cells
  • NADPH oxidase
  • Neovascularization
  • Reactive oxygen species
  • Stromal derived factor
  • Vasculogenesis

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of nox2-based NADPH 0xidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. / Urao, Norifumi; Inomata, Hyoe; Razvi, Masooma; Kim, Ha Won; Wary, Kishore; McKinney, Ronald; Fukai, Tohru; Fukai, Masuko.

In: Circulation research, Vol. 103, No. 2, 18.07.2008, p. 212-220.

Research output: Contribution to journalArticle

@article{f9933f5bfd9b4b5cab6303667e1871d4,
title = "Role of nox2-based NADPH 0xidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia",
abstract = "Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs). Postnatal neovascularization depends on not only angiogenesis but also vasculogenesis, which is mediated through mobilization of EPCs from BM and their recruitment to the ischemic sites. Reactive oxygen species (ROS) derived from Nox2-based NADPH oxidase play an important role in postnatal neovascularization; however, their role in BM and EPC function is unknown. Here we show that hindlimb ischemia of mice significantly increases Nox2 expression and ROS production in BM-mononuclear cells (BMCs), which is associated with an increase in circulating EPC-like cells. Mice lacking Nox2 show reduction of ischemia-induced flow recovery, ROS levels in BMCs, as well as EPC mobilization from BM. Transplantation of wild-type (WT)-BM into Nox2-deficient mice rescues the defective neovascularization, whereas WT mice transplanted with Nox2-deficient BM show reduced flow recovery and capillary density compared to WT-BM transplanted control. Intravenous infusion of WT- and Nox2-deficient BMCs into WT mice reveals that neovascularization and homing capacity are impaired in Nox2-deficient BMCs in vivo. In vitro, Nox2-deficient c-kitLin BM stem/progenitor cells show impaired chemotaxis and invasion as well as polarization of actins in response to stromal derived factor (SDF), which is associated with blunted SDF-1-mediated phosphorylation of Akt. In conclusion, Nox2-derived ROS in BM play a critical role in mobilization, homing, and angiogenic capacity of EPCs and BM stem/progenitor cells, thereby promoting revascularization of ischemic tissue. Thus, NADPH oxidase in BM and EPCs is potential therapeutic targets for promoting neovascularization in ischemic cardiovascular diseases.",
keywords = "Angiogenesis, Endothelial progenitor cells, NADPH oxidase, Neovascularization, Reactive oxygen species, Stromal derived factor, Vasculogenesis",
author = "Norifumi Urao and Hyoe Inomata and Masooma Razvi and Kim, {Ha Won} and Kishore Wary and Ronald McKinney and Tohru Fukai and Masuko Fukai",
year = "2008",
month = "7",
day = "18",
doi = "10.1161/CIRCRESAHA.108.176230",
language = "English (US)",
volume = "103",
pages = "212--220",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Role of nox2-based NADPH 0xidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia

AU - Urao, Norifumi

AU - Inomata, Hyoe

AU - Razvi, Masooma

AU - Kim, Ha Won

AU - Wary, Kishore

AU - McKinney, Ronald

AU - Fukai, Tohru

AU - Fukai, Masuko

PY - 2008/7/18

Y1 - 2008/7/18

N2 - Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs). Postnatal neovascularization depends on not only angiogenesis but also vasculogenesis, which is mediated through mobilization of EPCs from BM and their recruitment to the ischemic sites. Reactive oxygen species (ROS) derived from Nox2-based NADPH oxidase play an important role in postnatal neovascularization; however, their role in BM and EPC function is unknown. Here we show that hindlimb ischemia of mice significantly increases Nox2 expression and ROS production in BM-mononuclear cells (BMCs), which is associated with an increase in circulating EPC-like cells. Mice lacking Nox2 show reduction of ischemia-induced flow recovery, ROS levels in BMCs, as well as EPC mobilization from BM. Transplantation of wild-type (WT)-BM into Nox2-deficient mice rescues the defective neovascularization, whereas WT mice transplanted with Nox2-deficient BM show reduced flow recovery and capillary density compared to WT-BM transplanted control. Intravenous infusion of WT- and Nox2-deficient BMCs into WT mice reveals that neovascularization and homing capacity are impaired in Nox2-deficient BMCs in vivo. In vitro, Nox2-deficient c-kitLin BM stem/progenitor cells show impaired chemotaxis and invasion as well as polarization of actins in response to stromal derived factor (SDF), which is associated with blunted SDF-1-mediated phosphorylation of Akt. In conclusion, Nox2-derived ROS in BM play a critical role in mobilization, homing, and angiogenic capacity of EPCs and BM stem/progenitor cells, thereby promoting revascularization of ischemic tissue. Thus, NADPH oxidase in BM and EPCs is potential therapeutic targets for promoting neovascularization in ischemic cardiovascular diseases.

AB - Bone marrow (BM) is the major reservoir for endothelial progenitor cells (EPCs). Postnatal neovascularization depends on not only angiogenesis but also vasculogenesis, which is mediated through mobilization of EPCs from BM and their recruitment to the ischemic sites. Reactive oxygen species (ROS) derived from Nox2-based NADPH oxidase play an important role in postnatal neovascularization; however, their role in BM and EPC function is unknown. Here we show that hindlimb ischemia of mice significantly increases Nox2 expression and ROS production in BM-mononuclear cells (BMCs), which is associated with an increase in circulating EPC-like cells. Mice lacking Nox2 show reduction of ischemia-induced flow recovery, ROS levels in BMCs, as well as EPC mobilization from BM. Transplantation of wild-type (WT)-BM into Nox2-deficient mice rescues the defective neovascularization, whereas WT mice transplanted with Nox2-deficient BM show reduced flow recovery and capillary density compared to WT-BM transplanted control. Intravenous infusion of WT- and Nox2-deficient BMCs into WT mice reveals that neovascularization and homing capacity are impaired in Nox2-deficient BMCs in vivo. In vitro, Nox2-deficient c-kitLin BM stem/progenitor cells show impaired chemotaxis and invasion as well as polarization of actins in response to stromal derived factor (SDF), which is associated with blunted SDF-1-mediated phosphorylation of Akt. In conclusion, Nox2-derived ROS in BM play a critical role in mobilization, homing, and angiogenic capacity of EPCs and BM stem/progenitor cells, thereby promoting revascularization of ischemic tissue. Thus, NADPH oxidase in BM and EPCs is potential therapeutic targets for promoting neovascularization in ischemic cardiovascular diseases.

KW - Angiogenesis

KW - Endothelial progenitor cells

KW - NADPH oxidase

KW - Neovascularization

KW - Reactive oxygen species

KW - Stromal derived factor

KW - Vasculogenesis

UR - http://www.scopus.com/inward/record.url?scp=48849116997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48849116997&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.108.176230

DO - 10.1161/CIRCRESAHA.108.176230

M3 - Article

VL - 103

SP - 212

EP - 220

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 2

ER -